文献速递妇科

肥胖在早期宫颈癌治疗决策中的作用

The role of obesity in treatment planning for early-stage cervical cancer.
PubMed 文献 · Gynecol Oncol · 2023-12-21

肥胖与分配至RT独立相关;RH组中肥胖与非肥胖患者的无复发生存和总生存无差异。

要点

  • 肥胖(BMI>30)与分配至首选放疗独立相关,但肥胖本身不应作为选择放疗的唯一依据。
  • RH组中肥胖患者手术时间更长、更多限制生活的合并症,但生存结局与非肥胖患者无差异。
  • 多变量分析显示治疗方式与总生存无关,肿瘤较大、合并症多和复发是总生存较差的显著预测因素。

核心结论

  • 在适合RH的宫颈癌患者中,BMI与分配至RT独立相关;肥胖患者行RH可行且安全,无复发生存和总生存与非肥胖患者无差异,故决定分配至RT不应仅基于肥胖。

主要发现

  • RT组(n=39,15%)较RH组(n=221,85%)BMI更高(p=0.004)、年龄更大(p<0.001)、更多限制生活的合并症(p<0.001)、肿瘤更大(p=0.001)、临床分期更高(p=0.013)。
  • 多变量生存分析显示治疗方式与总生存无差异;总生存较差的显著预测因素为肿瘤较大、限制生活的合并症数量多和复发。
  • RH组中肥胖患者手术时间更长(p=0.01)、更多限制生活的合并症(p=0.02);人口学或临床病理特征、手术结局、无复发生存或总生存与非肥胖患者无差异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Optimal management of obese patients with early-stage cervical cancer is debated despite evidence of non-inferior survival in obese patients undergoing radical hysterectomy with pelvic lymphadenectomy (RH) compared to primary radiation with or without radiosensitizing chemotherapy (RT). Objectives included describing patient factors affecting disposition to RH versus RT; comparing RH outcomes for obese (BMI >30 mg/m2) and non-obese patients; and comparing differences in recurrence free survival (RFS) and overall survival (OS). METHODS: This was a single institution cohort study of all cervical cancer patients who underwent RH or were candidates for RH based on clinical stage. Demographic, clinicopathologic and treatment outcomes were collected and analyzed. RESULTS: RT patients (n = 39, 15%) had a higher BMI (p = 0.004), older age (p < 0.001), more life-limiting comorbidities (LLC) (p < 0.001), larger tumor size (p = 0.001), and higher clinical stage (p = 0.013) compared to RH patients (n = 221, 85%). On multivariable survival analysis there was no difference in OS based on treatment modality; significant predictors of worse OS were larger tumor size, higher number of LLC and recurrence. Among the RH group, obese patients had a longer operative time (p = 0.01) and more LLC (p = 0.02); there were no differences in demographic or clinicopathologic characteristics, operative outcomes, RFS or OS compared to non-obese patients. CONCLUSION: In this cohort of RH-eligible cervical cancer patients, BMI was independently associated with disposition to RT. Studies demonstrate that RH is feasible and safe in obese patients with no difference in RFS or OS when compared to non-obese patients. Thus, the decision for disposition to RT should not be based on obesity alone.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Rives TA, Orellana TJ, Mumford BS, et al. The role of obesity in treatment planning for early-stage cervical cancer. Gynecol Oncol. 2023. PMID: 38134755. doi:10.1016/j.ygyno.2023.12.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。